On the other hand, it could be assumed that patients who were TTF-1-negative were resistant to numerous cytotoxic chemotherapeutic agents and may not benefit from the use of PEM when even patients with nonsq NSCLC have resulting interstitial pneumonia or renal dysfunction. Here, TTF1 is linked to non-small cell lung carcinoma.